These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 11116449)

  • 1. [Epidemiology of ovarian cancer and female sex hormones].
    Khalil MR
    Ugeskr Laeger; 2000 Nov; 162(47):6395-8. PubMed ID: 11116449
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endogenous hormones and ovarian cancer: epidemiology and current hypotheses.
    Lukanova A; Kaaks R
    Cancer Epidemiol Biomarkers Prev; 2005 Jan; 14(1):98-107. PubMed ID: 15668482
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk factors for ovarian cancer: an overview with emphasis on hormonal factors.
    Salehi F; Dunfield L; Phillips KP; Krewski D; Vanderhyden BC
    J Toxicol Environ Health B Crit Rev; 2008 Mar; 11(3-4):301-21. PubMed ID: 18368558
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The possible role of female sex hormones in milk from pregnant cows in the development of breast, ovarian and corpus uteri cancers.
    Ganmaa D; Sato A
    Med Hypotheses; 2005; 65(6):1028-37. PubMed ID: 16125328
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Review of epidemiological evidence for reproductive and hormonal factors in relation to the risk of epithelial ovarian malignancies.
    Riman T; Nilsson S; Persson IR
    Acta Obstet Gynecol Scand; 2004 Sep; 83(9):783-95. PubMed ID: 15315588
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Infertility as a cancer risk factor - a review.
    Cetin I; Cozzi V; Antonazzo P
    Placenta; 2008 Oct; 29 Suppl B():169-77. PubMed ID: 18790330
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Epidemiology of ovarian cancer].
    Mosgaard BJ; Lidegaard O
    Ugeskr Laeger; 1996 Sep; 158(37):5150-3. PubMed ID: 8848846
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epidemiology of ovarian cancer.
    Permuth-Wey J; Sellers TA
    Methods Mol Biol; 2009; 472():413-37. PubMed ID: 19107446
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epidemiology and etiology of ovarian cancer: a review.
    Heintz AP; Hacker NF; Lagasse LD
    Obstet Gynecol; 1985 Jul; 66(1):127-35. PubMed ID: 3892386
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The epidemiology of sex steroid hormones and their signaling and metabolic pathways in the etiology of prostate cancer.
    Platz EA; Giovannucci E
    J Steroid Biochem Mol Biol; 2004 Nov; 92(4):237-53. PubMed ID: 15663987
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of oral contraceptive use, other contraceptive methods, and infertility with ovarian cancer risk.
    Tworoger SS; Fairfield KM; Colditz GA; Rosner BA; Hankinson SE
    Am J Epidemiol; 2007 Oct; 166(8):894-901. PubMed ID: 17656616
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Timing of pregnancy and the risk of epithelial ovarian cancer.
    Whiteman DC; Siskind V; Purdie DM; Green AC
    Cancer Epidemiol Biomarkers Prev; 2003 Jan; 12(1):42-6. PubMed ID: 12540502
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hormone replacement therapy and cancer.
    Gynecol Endocrinol; 2001 Dec; 15(6):453-65. PubMed ID: 11826770
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endogenous steroid hormone concentrations and risk of breast cancer among premenopausal women.
    Eliassen AH; Missmer SA; Tworoger SS; Spiegelman D; Barbieri RL; Dowsett M; Hankinson SE
    J Natl Cancer Inst; 2006 Oct; 98(19):1406-15. PubMed ID: 17018787
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum sex steroids in premenopausal women and breast cancer risk within the European Prospective Investigation into Cancer and Nutrition (EPIC).
    Kaaks R; Berrino F; Key T; Rinaldi S; Dossus L; Biessy C; Secreto G; Amiano P; Bingham S; Boeing H; Bueno de Mesquita HB; Chang-Claude J; Clavel-Chapelon F; Fournier A; van Gils CH; Gonzalez CA; Gurrea AB; Critselis E; Khaw KT; Krogh V; Lahmann PH; Nagel G; Olsen A; Onland-Moret NC; Overvad K; Palli D; Panico S; Peeters P; Quirós JR; Roddam A; Thiebaut A; Tjønneland A; Chirlaque MD; Trichopoulou A; Trichopoulos D; Tumino R; Vineis P; Norat T; Ferrari P; Slimani N; Riboli E
    J Natl Cancer Inst; 2005 May; 97(10):755-65. PubMed ID: 15900045
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ovarian function in women immediately post partum.
    Acar B; Fleming R; Macnaughton MC; Coutts JR
    Obstet Gynecol; 1981 Apr; 57(4):468-72. PubMed ID: 7243096
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum sex hormones and breast cancer risk factors in postmenopausal women.
    Lamar CA; Dorgan JF; Longcope C; Stanczyk FZ; Falk RT; Stephenson HE
    Cancer Epidemiol Biomarkers Prev; 2003 Apr; 12(4):380-3. PubMed ID: 12692114
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ovarian cancer hormonal and environmental risk effect.
    Vo C; Carney ME
    Obstet Gynecol Clin North Am; 2007 Dec; 34(4):687-700, viii. PubMed ID: 18061864
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incessant ovulation, mucin 1 immunity, and risk for ovarian cancer.
    Terry KL; Titus-Ernstoff L; McKolanis JR; Welch WR; Finn OJ; Cramer DW
    Cancer Epidemiol Biomarkers Prev; 2007 Jan; 16(1):30-5. PubMed ID: 17220329
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Controversial issues in climacteric medicine II. Hormone replacement therapy and cancer. International Menopause Society Expert Workshop. 9-12 June 2001, Opera del Duomo, Pisa, Italy.
    Genazzani AR; Gadducci A; Gambacciani M
    Climacteric; 2001 Sep; 4(3):181-93. PubMed ID: 11588941
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.